ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,0874
-0,19%
Bitcoin
66.735,07
-0,31%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. DICE Therapeutics Inc (DICE)

  7. DICE Therapeutics Inc (DICE) News

DICE

DICE Therapeutics (DICE)

DICE Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DICE
DatumZeitQuelleÜberschriftSymbolFirma
21/08/202314h00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:DICEDICE Therapeutics Inc
11/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DICEDICE Therapeutics Inc
09/08/202322h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202322h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202322h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202322h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202322h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202322h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202315h47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DICEDICE Therapeutics Inc
09/08/202315h45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DICEDICE Therapeutics Inc
09/08/202315h42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DICEDICE Therapeutics Inc
09/08/202315h38Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:DICEDICE Therapeutics Inc
09/08/202315h32Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DICEDICE Therapeutics Inc
09/08/202315h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DICEDICE Therapeutics Inc
09/08/202315h20Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DICEDICE Therapeutics Inc
09/08/202315h02PR Newswire (US)Lilly Completes Acquisition of DICE TherapeuticsNASDAQ:DICEDICE Therapeutics Inc
08/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DICEDICE Therapeutics Inc
25/07/202313h11Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DICEDICE Therapeutics Inc
25/07/202312h55PR Newswire (US)Lilly Announces Extension of Tender Offer to Acquire DICENASDAQ:DICEDICE Therapeutics Inc
17/07/202323h23Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DICEDICE Therapeutics Inc
30/06/202322h22Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:DICEDICE Therapeutics Inc
23/06/202323h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DICEDICE Therapeutics Inc
23/06/202323h11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DICEDICE Therapeutics Inc
22/06/202322h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DICEDICE Therapeutics Inc
21/06/202323h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DICEDICE Therapeutics Inc
20/06/202322h07Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DICEDICE Therapeutics Inc
20/06/202316h15Dow Jones NewsTrending: Eli Lilly Buys DICE Therapeutics in Deal Worth $2.4 BillionNASDAQ:DICEDICE Therapeutics Inc
20/06/202314h21Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:DICEDICE Therapeutics Inc
20/06/202313h42Dow Jones NewsEli Lilly to Acquire DICE Therapeutics for $2.4 BillionNASDAQ:DICEDICE Therapeutics Inc
20/06/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DICEDICE Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DICE

Kürzlich von Ihnen besucht

USOTC
UDIRF
United Internet (PK)
BIT
VUSC
Exchange Traded Fund Van...
COIN
GDXBTC
Gridex
BIT
F17271
Vontobel Financial Produ...
BIT
UR9UGT
UniCredit Bank
BIT
UB3YG5
Unicredit Bank
BIT
UC8YK9
Unicredit Bank
AMEX
JPAN
Matthews Japan Active ETF
BIT
P1DNV4
BNP Paribas Issuance
BIT
UC5R43
Unicredit Bank
COIN
IMGNAIETH
Image Generation AI
BIT
F18190
Vontobel Financial Produ...
COIN
VPSUSD
NASDAQ
XSPL
TSX
DII.A
Dorel Industries
BIT
P22CW7
NLBNPIT22CW7 20351221 12...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten